Augurex Life Sciences Corp.
1 known investors
Augurex develops biomarker-driven clinical diagnostic tests for autoimmune conditions, including rheumatoid arthritis and axial spondyloarthritis. Its diagnostic solutions support early diagnosis, prognosis, and ongoing management for patients and healthcare providers.